EARLY PRECLINICAL ALZHEIMER'S DISEASE

Clinical trials for EARLY PRECLINICAL ALZHEIMER'S DISEASE explained in plain language.

Never miss a new study

Get alerted when new EARLY PRECLINICAL ALZHEIMER'S DISEASE trials appear

Sign up with your email to follow new studies for EARLY PRECLINICAL ALZHEIMER'S DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Race to stop Alzheimer's before it starts: major drug trial targets silent brain changes

Prevention Ongoing

This large study is testing whether the drug lecanemab can prevent or delay Alzheimer's disease in people who have early signs of the disease in their brains but do not yet have memory problems or other symptoms. It involves 1,400 participants aged 55-80 who have intermediate or …

Matched conditions: EARLY PRECLINICAL ALZHEIMER'S DISEASE

Phase: PHASE3 • Sponsor: Eisai Inc. • Aim: Prevention

Last updated Mar 09, 2026 14:23 UTC

EARLY PRECLINICAL ALZHEIMER'S DISEASE

Get alerted when new EARLY PRECLINICAL ALZHEIMER'S DISEASE trials appear

Race to stop Alzheimer's before it starts: major drug trial targets silent brain changes